Buyer
Seller
Min Order Qty 1 cm
Accept Small Orders
Product not available
Generic Name: Ribociclib
Dosage: Kryxana 200mg Tablet
Kryxana (200mg) is a medication primarily used in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer.
Ribociclib is indicated for postmenopausal women with HR+/HER2- advanced breast cancer in combination with an aromatase inhibitor as initial endocrine-based therapy.
It is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, which helps slow down the progression of cancer cells by interfering with their ability to divide and grow.
It is usually used in combination with other hormonal therapies like aromatase inhibitors to enhance its effectiveness.
Ribociclib has demonstrated improved progression-free survival in clinical trials, making it an important treatment option for HR+ breast cancer.
Contact us for
Established in: | 2010 |
Bussiness Type: | Sole Proprietorship |
Bussiness Type: | Merchant, Service Provider |
MSME: | Yes |
Countries exporting to: | Afghanistan, Algeria, Angola, Anguilla, Antigua And Barbuda, Azerbaijan, Benin, Bhutan, Botswana, Burkina Faso, Burundi, Cambodia, Cameroon, Cayman Islands, Chad, Congo, Costa Rica, Cote D'Ivoire (Ivory Coast), Croatia (Hrvatska), Cuba, Dominica, Dominican Republic, Estonia, Ethiopia, Fiji Islands, French Guiana, Gabon, Gambia The, Georgia, Ghana, Greece, Guadeloupe, Guatemala, Guyana, Haiti, Honduras, India, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lesotho, Lithuania, Malawi, Maldives, Mali, Malta, Marshall Islands, Morocco, Mozambique, Myanmar, Nepal, Nigeria, Oman, Papua new Guinea, Peru, Philippines, Saint Kitts And Nevis, Saint Lucia, Samoa, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, South Sudan, Sudan, Tajikistan, Tanzania, Togo, Tonga, Tunisia, Turkey, Uganda, Uzbekistan, Venezuela, Vietnam, Yemen, Zambia |
Export Turnover (3 years): | US$10,000 to US$50,000 |
Certifications: | MSME Udyam |
Countries would like to export to: | Australia, Bangladesh, Barbados, Belgium, Bermuda, Bolivia, Bosnia and Herzegovina, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cayman Islands, Colombia, Congo The Democratic Republic Of The, Croatia (Hrvatska), Cuba, Czech Republic, Denmark, Djibouti, Ecuador, Equatorial Guinea, Estonia, Ethiopia, Fiji Islands, French Guiana, French Southern Territories, Gibraltar, Greece, Greenland, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Iran, Iraq, Ireland, Israel, Jamaica, Jordan, Kazakhstan, Kuwait, Kyrgyzstan, Latvia, Liberia, Lithuania, Malawi, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nicaragua, Niger, Nigeria, Oman, Panama, Papua new Guinea, Peru, Philippines, Pitcairn Island, Seychelles, Sweden, Taiwan, Tanzania, Tonga, Trinidad And Tobago, Turkey, Virgin Islands (British), Virgin Islands (US), Western Sahara, Zimbabwe |
No of employees: | 1-10 |